CEO Buys 69k Bionano Options Amid 75% Stock Slide: What It Means for Investors
CEO’s zero‑cost option buy at Bionano signals insider confidence amid a steep 75% stock decline—watch upcoming filings for potential turnaround moves.
4 minutes to read
Bionano Genomics Inc
BNGO Insider Moves Signal Confidence Amid Reimbursement Shift & Tech Boom
BNGO insider buying signals executive confidence while market trends in genomics reimbursement and tech adoption hint at a possible turnaround for the healthcare‑tech firm.
5 minutes to read